Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Bengü Saylan"'
Autor:
Omer Ayten, Insa Gul Ekiz Iscanli, Kadir Canoglu, Cengiz Ozdemir, Bengü Saylan, Tayfun Caliskan, Hasan Akin, Cağatay Tezel
Publikováno v:
Journal of Cardiothoracic and Vascular Anesthesia. 36:2948-2953
The authors aimed to evaluate the characteristics and management outcomes of patients who developed tracheal stenosis after invasive mechanical ventilation (IMV) due to COVID-19.The data of 7 patients with tracheal stenosis and 201 patients without t
Autor:
Ömer Ayten, İnşa Gül Ekiz İşcanlı, Ekiz İşcanlı, Gözde Kalbaran Kısmet, Cengiz Özdemir, Bengü Şaylan
Publikováno v:
İstanbul Medical Journal, Vol 23, Iss 2, Pp 113-118 (2022)
Introduction:The efficacy and safety of immunosuppressive therapy in Coronavirus disease-2019 (COVID-19) still controversial. We evaluated the effects of immunosuppressive therapy on mortality in patients followed in the intensive care units (ICU) du
Externí odkaz:
https://doaj.org/article/ff6de0c177dd46cf88108919842ac4a1
Publikováno v:
Annals of Saudi Medicine, Vol 42, Iss 1, Pp 45-51 (2022)
BACKGROUND: Pneumonia is among the most serious infections in the elderly. The evaluation of prognosis and predicting the outcome is essential in managing the treatment of patients with pneumonia. OBJECTIVE: Evaluate factors that might affect the mor
Externí odkaz:
https://doaj.org/article/d3273699776e42b78f877ddd89f73927
Publikováno v:
Cirugía y Cirujanos, Vol 90, Iss 4 (2022)
Objetivo: Nos propusimos evaluar el efecto de la COVID-19 en los resultados de los pacientes quirúrgicos y los factores relacionados con las complicaciones postoperatorias y la mortalidad. Métodos: Se incluyeron los pacientes hospitalizados sometid
Externí odkaz:
https://doaj.org/article/79679bf99e964b8d838310bd2ce70ccc
Autor:
Seyma Baslilar, Bengu Saylan
Publikováno v:
Annals of Saudi Medicine, Vol 41, Iss 5, Pp 268-273 (2021)
BACKGROUND: The angiotensin-converting enzyme inhibitors (ACEI) and angiotensin II receptor blockers (ARBs) are widely used for the treatment of hypertension (HT). Whether the use of these drugs increases the infectivity of novel coronavirus and resu
Externí odkaz:
https://doaj.org/article/151dc1962fe54498bb6e4427e08addf7
Publikováno v:
Tobacco Induced Diseases, Vol 19, Iss June, Pp 1-9 (2021)
Introduction Long-term outcomes of smoking cessation treatments are crucial to optimize standards of cessation services, which are known to prevent excess morbidity and mortality. This study aimed to evaluate long-term outcomes of a smoking cessation
Externí odkaz:
https://doaj.org/article/71c4411dca784ca481a96b02e243edd0
Autor:
Cesur Samanci, Bengu Saylan, Gokce Gulsen, Yuksel Akkaya, Melike Yesildal, Sinem Akkaya Isik, Fethi Emre Ustabasioglu
Publikováno v:
Clinical and Experimental Hypertension, Vol 43, Iss 4, Pp 341-348 (2021)
Objective There is not enough data on the effect of angiotensin-converting enzyme inhibitors (ACEIs)/angiotensin receptor blockers (ARBs) on lung involvement in patients with COVID-19 pneumonia and hypertension (HT). Our aim was to compare the lung i
Externí odkaz:
https://doaj.org/article/dbf33f5f6de8458eb148b71f084b2545
Autor:
Nurullah Okumuş, Neşe Demirtürk, Rıza Aytaç Çetinkaya, Rahmet Güner, İsmail Yaşar Avcı, Semiha Orhan, Petek Konya, Bengü Şaylan, Ayşegül Karalezli, Levent Yamanel, Bircan Kayaaslan, Gülden Yılmaz, Ümit Savaşçı, Fatma Eser, Gürhan Taşkın
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-11 (2021)
Abstract Background and objectives An effective treatment option is not yet available for SARS-CoV2, which causes the COVID-19 pandemic and whose effects are felt more and more every day. Ivermectin is among the drugs whose effectiveness in treatment
Externí odkaz:
https://doaj.org/article/5462c2a8a64b4f2690df4fb170b80248
Autor:
Kadir Canoglu, Bengu Saylan
Publikováno v:
Annals of Saudi Medicine, Vol 40, Iss 6, Pp 462-468 (2020)
BACKGROUND: Venous thromboembolism or extensive thrombosis is relatively common in patients with severe COVID-19 infection and has been associated with increased mortality. During the current COVID-19 pandemic, several prophylactic doses and types of
Externí odkaz:
https://doaj.org/article/4f96cdcbf6964ff28217745dc4b007ed
Autor:
Omer Ayten, Bengu Saylan
Publikováno v:
Southern African Journal of Infectious Diseases, Vol 35, Iss 1, Pp e1-e7 (2020)
Background: Currently there is no proven medical treatment for COVID-19. We aimed to determine the factors affecting mortality and changes in clinical and laboratory findings in patients with severe COVID-19 pneumonia treated with lopinavir/ritonavir
Externí odkaz:
https://doaj.org/article/892aff14d15d4bbaa893061bf93b08c5